Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.

<h4>Background</h4>To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure.<h4>Methods</h4>We rec...

Full description

Bibliographic Details
Main Authors: Masashi Nishimura, Satoshi Sugawa, Shinichiro Ota, Etsuko Suematsu, Masahiro Shinoda, Masaharu Shinkai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0267566
_version_ 1828263254618537984
author Masashi Nishimura
Satoshi Sugawa
Shinichiro Ota
Etsuko Suematsu
Masahiro Shinoda
Masaharu Shinkai
author_facet Masashi Nishimura
Satoshi Sugawa
Shinichiro Ota
Etsuko Suematsu
Masahiro Shinoda
Masaharu Shinkai
author_sort Masashi Nishimura
collection DOAJ
description <h4>Background</h4>To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure.<h4>Methods</h4>We recruited 685 healthcare workers (HCW's) at Tokyo Shinagawa Hospital prior to the vaccination with COVID-19 vaccine. Sera of the subjects were tested by assays for the titer of IgG against S protein's receptor binding domain (IgG (RBD)) or IgG against nucleocapsid protein (IgG (N)) of SARS-CoV-2. Together with PCR data, the positive rates by these methods were evaluated.<h4>Results</h4>Overall positive rates among HCW's by PCR, IgG (RBD), IgG (N) with a cut-off of 1.4 S/C (IgG (N)1.4), and IgG (N) with a cut-off of 0.2 S/C (IgG (N)0.2) were 3.5%, 9.5%, 6.1%, and 27.7%, respectively. Positive rates of HCW's working in COVID-19 ward were significantly higher than those of HCW's working in non-COVID-19 ward by all the four methods. Concordances of IgG (RBD), IgG (N)1.4, and IgG (N)0.2 against PCR were 97.1%, 71.4%, and 88.6%, respectively. By subtracting the positive rates of PCR from that of IgG (RBD), the rate of overall silent infection and that of HCW's in COVID-19 ward were estimated to be 6.0% and 21.1%, respectively.<h4>Conclusions</h4>For the prevention of nosocomial infection of SARS-CoV-2, identification of silent infection is essential. For the detection of ongoing infection, periodical screening with IgG (RBD) in addition to PCR would be an effective measure. For the surveillance of morbidity in the population, on the other hand, IgG (N)0.2 could be the most reliable indicator among the three serological tests.
first_indexed 2024-04-13T04:09:42Z
format Article
id doaj.art-4ce9a1311fd7468eba3b822c278ae278
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T04:09:42Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4ce9a1311fd7468eba3b822c278ae2782022-12-22T03:03:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01175e026756610.1371/journal.pone.0267566Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.Masashi NishimuraSatoshi SugawaShinichiro OtaEtsuko SuematsuMasahiro ShinodaMasaharu Shinkai<h4>Background</h4>To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure.<h4>Methods</h4>We recruited 685 healthcare workers (HCW's) at Tokyo Shinagawa Hospital prior to the vaccination with COVID-19 vaccine. Sera of the subjects were tested by assays for the titer of IgG against S protein's receptor binding domain (IgG (RBD)) or IgG against nucleocapsid protein (IgG (N)) of SARS-CoV-2. Together with PCR data, the positive rates by these methods were evaluated.<h4>Results</h4>Overall positive rates among HCW's by PCR, IgG (RBD), IgG (N) with a cut-off of 1.4 S/C (IgG (N)1.4), and IgG (N) with a cut-off of 0.2 S/C (IgG (N)0.2) were 3.5%, 9.5%, 6.1%, and 27.7%, respectively. Positive rates of HCW's working in COVID-19 ward were significantly higher than those of HCW's working in non-COVID-19 ward by all the four methods. Concordances of IgG (RBD), IgG (N)1.4, and IgG (N)0.2 against PCR were 97.1%, 71.4%, and 88.6%, respectively. By subtracting the positive rates of PCR from that of IgG (RBD), the rate of overall silent infection and that of HCW's in COVID-19 ward were estimated to be 6.0% and 21.1%, respectively.<h4>Conclusions</h4>For the prevention of nosocomial infection of SARS-CoV-2, identification of silent infection is essential. For the detection of ongoing infection, periodical screening with IgG (RBD) in addition to PCR would be an effective measure. For the surveillance of morbidity in the population, on the other hand, IgG (N)0.2 could be the most reliable indicator among the three serological tests.https://doi.org/10.1371/journal.pone.0267566
spellingShingle Masashi Nishimura
Satoshi Sugawa
Shinichiro Ota
Etsuko Suematsu
Masahiro Shinoda
Masaharu Shinkai
Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
PLoS ONE
title Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
title_full Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
title_fullStr Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
title_full_unstemmed Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
title_short Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
title_sort detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests
url https://doi.org/10.1371/journal.pone.0267566
work_keys_str_mv AT masashinishimura detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests
AT satoshisugawa detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests
AT shinichiroota detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests
AT etsukosuematsu detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests
AT masahiroshinoda detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests
AT masaharushinkai detectionofsilentinfectionofsevereacuterespiratorysyndromecoronavirus2byserologicaltests